Sunder-Plassmann G - Search Results

1

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy.

Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G. Aigner C, et al. Clin Kidney J. 2019 Apr 21;12(3):333-337. doi: 10.1093/ckj/sfz040. eCollection 2019 Jun. Clin Kidney J. 2019. PMID: 31198225 Free PMC article.

2

The endocardial binary appearance ('binary sign') is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophy.

Mundigler G, Gaggl M, Heinze G, Graf S, Zehetgruber M, Lajic N, Voigtländer T, Mannhalter C, Sunder-Plassmann R, Paschke E, Fauler G, Sunder-Plassmann G. Mundigler G, et al. Eur J Echocardiogr. 2011 Oct;12(10):744-9. doi: 10.1093/ejechocard/jer112. Epub 2011 Aug 20. Eur J Echocardiogr. 2011. PMID: 21857019

3

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients.

Sunder-Plassmann G, Reinke P, Rath T, Wiecek A, Nowicki M, Moore R, Lutz J, Gaggl M, Ferkl M. Sunder-Plassmann G, et al. Transpl Int. 2012 Jun;25(6):680-6. doi: 10.1111/j.1432-2277.2012.01475.x. Epub 2012 Apr 16. Transpl Int. 2012. PMID: 22500920 Free PMC article. Clinical Trial.

4

A single lung transplant in a patient with fabry disease: causality or far-fetched? A case report.

Gaggl M, Kain R, Jaksch P, Haider D, Mundigler G, Voigtländer T, Sunder-Plassmann R, Rommer P, Klepetko W, Sunder-Plassmann G. Gaggl M, et al. Case Rep Transplant. 2013;2013:905743. doi: 10.1155/2013/905743. Epub 2013 Apr 7. Case Rep Transplant. 2013. PMID: 23691425 Free PMC article.

5

Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).

Gaggl M, Cejka D, Plischke M, Heinze G, Fraunschiel M, Schmidt A, Hörl WH, Sunder-Plassmann G. Gaggl M, et al. Trials. 2013 Jul 4;14:196. doi: 10.1186/1745-6215-14-196. Trials. 2013. PMID: 23826760 Free PMC article. Clinical Trial.

6

Effect of oral alkali supplementation on progression of chronic kidney disease.

Gaggl M, Sliber C, Sunder-Plassmann G. Gaggl M, et al. Curr Hypertens Rev. 2014;10(2):112-20. doi: 10.2174/1573402111666141231123314. Curr Hypertens Rev. 2014. PMID: 25549843 Review.

7

Interfering parameters in the determination of urinary globotriaosylceramide (Gb3) in patients with chronic kidney disease.

Gaggl M, Hofer M, Weidner S, Kleinert J, Fauler G, Wallner M, Kotanko P, Paschke E, Sunder-Plassmann G. Gaggl M, et al. J Nephrol. 2015 Dec;28(6):679-89. doi: 10.1007/s40620-015-0193-1. Epub 2015 Apr 10. J Nephrol. 2015. PMID: 25857295 Clinical Trial.

8

The Renal History of Fabry Disease.

Gaggl M, El-Hadi S, Aigner C, Sunder-Plassmann G. Gaggl M, et al. G Ital Nefrol. 2016 Feb;33 Suppl 66:33.S66.14. G Ital Nefrol. 2016. PMID: 26913882 Free article.

9

Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy.

Gaggl M, Lajic N, Heinze G, Voigtländer T, Sunder-Plassmann R, Paschke E, Fauler G, Sunder-Plassmann G, Mundigler G. Gaggl M, et al. Int J Med Sci. 2016 Apr 26;13(5):340-6. doi: 10.7150/ijms.14997. eCollection 2016. Int J Med Sci. 2016. PMID: 27226774 Free PMC article.

10

[Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].

Gaggl M, Aigner C, Sunder-Plassmann G, Schmidt A. Gaggl M, et al. Med Klin Intensivmed Notfmed. 2016 Jun;111(5):434-9. doi: 10.1007/s00063-016-0176-6. Epub 2016 Jun 2. Med Klin Intensivmed Notfmed. 2016. PMID: 27255224 Free PMC article. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page